Biocom

This week in Bay Area life sciences: 🧬 Addition Therapeutics shared preclinical proof‑of‑concept data at the ASGCT 29th Annual Meeting. 👁️ @BayerPharma announced plans to acquire Perfuse Therapeutics to strengthen its ophthalmology pipeline. ❤️ @Cytokinetics presented new MYOQORZO (aficamten) data at ESC Heart Failure 2026. Subscribe to receive the next newsletter in your inbox: bit.ly/40rlR8a

A reminder to join us for an exclusive webinar with the Advanced Research Projects Agency for Health (ARPA-H) designed to help organizations better understand how to leverage partnership opportunities within ARPA-H programs. Hear directly from Sam Gussman-Toh, lead program specialist for ARPA-H’s Small Business Program, as he shares insights into the agency’s research and funding programs in addition to how organizations can engage with ARPA-H. This free-to-attend virtual event will be held May 28, 2026, from 12 p.m. – 1 p.m. PDT. RSVP by May 27. Learn more: bit.ly/4tUCbv7

This week in San Diego life sciences: @Capricor filed a lawsuit against Nippon Shinyaku related to Duchenne drug pricing and launch issues; @aTyrNewsprovided a regulatory and clinical update for efzofitimod following an FDA Type C Meeting; @Inhibrx reported interim Phase 2 data for INBRX‑106. Subscribe: bit.ly/4iqn5b1

In this month’s Policy & Advocacy Newsletter, we cover the California governor’s proposal for a permanent R&D credit limitation, President Trump’s released FY27 budget request, a signal to new funding opportunities in the Greater LA region and more. Read the full newsletter here: bit.ly/40yIJCC

Science moves fast. Today is a reminder to slow down just enough to enjoy the ride. There is still time to stop by our @SANDAG Bike Anywhere Day pit stop and spend part of your morning with the Biocom team. Join us at Nourish Eats at One Alexandria Square for a free coffee cart, snacks, and giveaways. Thanks to everyone who has already biked by!

What does it take to move ocular melanoma therapeutics from translational strategy to patient impact? Join our member @pharmaron for its next BioInnovate webinar, featuring Sandeep Kumar and Dr. Arun Singh discussing the evolving landscape of ocular melanoma therapeutics. Register now: bit.ly/4nHDMlY

It's #NewMemberMonday! 💉 @ImmuneBridge manufactures high quality, scalable cell therapies at ultralow cost. 💼 @KSProp develops best‑in‑class laboratory and advanced manufacturing real estate for science‑driven companies. 🤖 @TactusAI automates laboratory operations by pairing humanoid robots with intelligent lab orchestration software to maximize throughput. ✨ Antheia applies advanced biosynthesis to rapidly produce high-value drug ingredients at commercial scale. 💊 Noven Pharmaceuticals commercializes transdermal prescription therapies to improve patient care. 🫀 Vasa Therapeutics discovers novel therapeutics targeting the biological drivers of cardiovascular aging.

Biking to work this Thursday? Be sure to plan your pit stop at Nourish Eats on the corner of N Torrey Pines and Science Park to meet the Biocom team!

Final call to participate in the 2026 Life Science Total Rewards Survey, powered by Marsh McLennan Agency in partnership with Biocom Institute. This is your last chance to contribute to one of the life science industry’s premier compensation benchmarking resources. If you haven’t participated yet, there's still time. This survey takes approximately 60–75 minutes to complete, and participating organizations will receive a complimentary copy of the full report once the survey closes. Complete the survey by May 22: bit.ly/48EBZHY Questions or access issues? Contact MW.SurveySupport-HRC@MarshMMA.com

From curiosity-driven discovery to life-changing breakthroughs, scientific innovation continues to shape the future of medicine and society. Join @ucsdbiosciences Dean Kit Pogliano and 2025 Nobel Laureate Fred Ramsdell on June 11 in San Diego or virtually for a Deep Look Public Speaker Series conversation on advancing biomedical research and strengthening public trust in science. Learn more and register: bit.ly/4wy87HE

Meet the esteemed speakers who will be sharing their insights on cross-border collaboration at our C-suite series event in South San Francisco on June 3. Learn more and register: bit.ly/3P19ca8

AI, cloud technology and advanced data tools are transforming the future of life science and healthcare. Join our member @Google for two upcoming West Coast events bringing together biotech, healthcare and digital health innovators: June 1 | San Francisco West Coast Bio 2026 Learn more: bit.ly/3R0Aj5P June 4 | San Diego West Coast Healthcare Summit 2026 Register: bit.ly/4uOJbtI

This week in the Bay Area life sciences: @AlamarBio launched a blood‑based pTau217 biomarker program for Alzheimer’s detection; @Corcept reported a two‑year overall survival benefit in a Phase 2 ALS study; @PliantTx dosed the first patient in a Phase 1b trial of PLN‑101095; @UnnatProducts raised $45M in Series B financing. Subscribe: bit.ly/40rlR8a

This week in San Diego life sciences: @HalozymeInc entered a global collaboration and license agreement with Oruka to develop ORKA‑001; @UCSanDiego Extended Studies launched an online pharma clinical, regulatory, and compliance course; @SolutionsRenovo expanded its Lab Asset Management Program to improve biotech uptime. Subscribe: bit.ly/4iqn5b1

Don’t miss the opportunity to participate in the 2026 Life Science Total Rewards Survey. Powered by Marsh McLennan Agency in partnership with Biocom Institute, this 60–75 minute survey is designed to help organizations make smarter compensation and talent decisions across the life science industry. Participating organizations will receive a complimentary copy of the full results after the survey closes. Take the survey before it closes on May 22: bit.ly/48EBZHY Questions or access issues? Contact MW.SurveySupport-HRC@MarshMMA.com

Biocom member @UCSDExtStudies is offering an online Pharma Clinical, Regulatory and Compliance course covering clinical trials, FDA regulations and pharmaceutical compliance. Strengthen your understanding of today’s drug development landscape. Learn more: bit.ly/4uH4woS

Working in transdermal drug delivery, neurology, women's health or rare diseases? Seeking a strategic licensing or partnership opportunity? Applications close Monday, May 25 for the opportunity to participate in1:1 partnering meetings with Noven Pharmaceuticals leadership during Biocom's Partnering Day on June 10 in San Diego. A subsidiary of Hisamitsu Pharmaceutical, Noven Pharmaceuticals is seeking strategic partners for asset licensing, external research agreements and regional partnerships focused on advancing innovative therapies through transdermal drug delivery technologies. Selected applicants will be notified by May 31. Apply here: bit.ly/4d5oV15 #Biocom #Partnering #LifeSciences #Pharma

What are the most common Washington DOSH compliance gaps in lab and biotech environments? Join an upcoming webinar with state and industry experts from Occupational Services to gain practical insight into DOSH requirements, frequent violations and actionable steps to reduce risk and strengthen your safety programs. Learn more and register: bit.ly/48WxeK4

Attention early-stage R&D companies in the Bay Area: @MBCBioLabs is now accepting applications for the 2026 ONO Golden Ticket Competition. Winners receive lab space and mentorship from ONO researchers and business leaders. Applications close June 5. Learn more: bit.ly/4trb4ac

It's #NewMemberMonday! ✨ AltruBio Inc. develops first in class immune modulators to treat diseases driven by immunology and inflammation. 💊 @AzoraTx develops novel clinical stage therapies for serious inflammatory diseases including hidradenitis suppurativa and ulcerative colitis. 🧪 @HygiaReagents manufactures GMP grade reagents, NGS solutions and CDMO style diagnostics to support biotech, pharma and diagnostic partners. 🧠 @Immunicom develops a non drug cancer therapy that harnesses the body’s natural immune system to improve outcomes with fewer side effects. 🔬 @PIHealthSc24325 delivers integrated drug discovery, development and API manufacturing to advance IND ready programs efficiently. 🧬 LSMC operates a scalable sequencing as a service platform that enables diagnostics and genomic initiatives without owning labs.